Joseph S. Dosch, Ph.D.
Affiliations: | 2011 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Cell BiologyGoogle:
"Joseph Dosch"Parents
Sign in to add mentorCharles Burant | grad student | 2011 | University of Michigan | |
(Examining the role of hedgehog signaling in the pancreatic tumor microenvironment.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Dosch J, Ziemke E, Wan S, et al. (2017) Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency. Oncotarget. 8: 65090-65099 |
Stacer AC, Wang H, Fenner J, et al. (2015) Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells. Molecular Imaging. 14: 7290201500016 |
Stacer AC, Wang H, Fenner J, et al. (2015) Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells. Molecular Imaging. 14: 414-28 |
Cavnar SP, Rickelmann AD, Meguiar KF, et al. (2015) Modeling Selective Elimination of Quiescent Cancer Cells from Bone Marrow. Neoplasia (New York, N.Y.). 17: 625-33 |
Ziemke EK, Dosch JS, Maust JD, et al. (2015) Sensitivity of KRAS Mutant Colorectal Cancers to Combination Therapy that Co-Targets MEK and CDK4/6. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Dosch JS, Ziemke EK, Shettigar A, et al. (2015) Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer. Cancer Research. 75: 4582-92 |
Dosch J, Ziemke E, Welling T, et al. (2015) Abstract 975: Monoclonal antibody targeting of ADAM17 is an effective treatment for metastatic colorectal cancer resulting in tumor growth control and reductions of cancer stem cells Cancer Research. 75: 975-975 |
Dosch JS, Ziemke EK, Shettigar A, et al. (2015) Abstract 1400: Evaluation of tumor-initiating cell populations in the KPC mouse model of pancreatic cancer Cancer Research. 75: 1400-1400 |
Ziemke E, Dosch J, Shettigar A, et al. (2014) Abstract 4541: Dual targeting of CDK4 and MEK as a combination treatment strategy for metastatic colorectal cancer Cancer Research. 74: 4541-4541 |
Nyati S, Schinske-Sebolt K, Pitchiaya S, et al. (2014) Abstract 1137: Bub1 is a key regulator of TGF-β signaling Cancer Research. 74: 1137-1137 |